692
Participants
Start Date
September 1, 2017
Primary Completion Date
December 31, 2020
Study Completion Date
December 31, 2020
Flucelvax Trivalent Influenza Vaccine
"Flucelvax is a cell culture seasonal trivalent influenza vaccine that contains the following influenza hemagglutinin antigens: 1) A/H1N1-like virus, 2) A/(H3N2)-like virus, 3) B/Yamagata lineage or B/Victoria lineage~Vaccine exposure in routine care (no vaccination per protocol)"
Flucelvax Quadrivalent Influenza Vaccine
"Flucelvax Quadrivalent is a cell culture seasonal quadrivalent influenza vaccine that contains the following influenza hemagglutinin antigens: 1) A/H1N1-like virus, 2) A/(H3N2)-like virus, 3) B/Yamagata lineage, 4) B/Victoria lineage~Vaccine exposure in routine care (no vaccination per protocol)"
Syneos Health, Wilmington
Seqirus
INDUSTRY